[1]
|
A. Jemal, R. Siegel, J. Xu and E. Ward, “Cancer statistics, 2010,” CA: A Cancer Journal for Clinicians, Vol. 60, No. 5, 2010, pp. 277-300. doi.org/10.3322/caac.20073
|
[2]
|
E. Langholz, P. Munkholm, M. Davidsen and V. Binder, “Colorectal Cancer Risk and Mortality in Patients with Ulcerative Colitis,” Gastroenterology, Vol. 103, No. 5, 1992, pp. 1444-1451.
|
[3]
|
W. Holtkamp, T. Stollberg and H. E. Reis, “Serum Interleukin-6 Is Related to Disease Activity but Not Disease Specificity in Inflammatory Bowel Disease,” Journal of Clinical Gastroenterology, Vol. 20, No. 2, 1995, pp. 123-126.
doi:10.1097/00004836-199503000-00010
|
[4]
|
C. Niederau, F. Backmerhoff, B. Schumacher and C. Niederau, “Inflammatory Mediators and Acute Phase Proteins in Patients with Crohn’s Disease and Ulcerative Colitis,” Hepatogastroenterology, Vol. 44, No. 13, 1997, pp. 90-107.
|
[5]
|
T. Kishimoto, “Interleukin-6: From Basic Science to Medicine—40 Years in Immunology,” Annual Review of Immunology, Vol. 23, 2005, pp. 1-21.
doi:10.1146/annurev.immunol.23.021704.115806
|
[6]
|
S. Liu, C. Ginestier and S.J. Ou, “Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks,” Cancer Reserch, Vol. 71, No. 6, 2011, pp. 614-624. doi:10.1158/0008-5472.CAN-10-0538
|
[7]
|
Z. Tang, M. Yu, F. Miller, R. S. Berk, G. Tromp and M. A. Kosir, “Increased Invasion through Basement Membrane by CXCL7-Transfected Breast Cells,” The American Journal of Surgery, Vol. 196, No. 5, 2008, pp. 690-696. doi:10.1016/j.amjsurg.2008.08.001
|
[8]
|
T. Taga and T. Kishimoto, “Gp130 and the Interleukin-6 Family of Cytokines”, Annual Review of Immunology, Vol. 15, 1997, pp. 797-815.
doi:10.1146/annurev.immunol.15.1.797
|
[9]
|
Z. Zhong, Z.Wen and J. E. Jr. Darnell, “Stat3: A STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Inter- leukin-6,” Science, Vol. 264, No. 5155, 1994, pp. 95-98.
doi:10.1126/science.8140422
|
[10]
|
T. Kordula, M. Bugno, J. Goldstein, and J. Travis, “Activation of Signal Transducer and Activator of Transcription-3 (Stat3) Expression by Interferon-Gamma and Interleukin-6 in Hepatoma Cells,” Biochemical and Biophysical Research Communications, Vol. 216, No. 3, 1995, pp. 999-1005. doi.org/10.1006/bbrc.1995.2719
|
[11]
|
T. Kusaba, T. Nakayama, K. Yamazumi, Y. Yakata, A. Yosizaki, T. Nagayasu and I. Sekine, “Expression of p-STAT3 in Human Colorectal Adenocarcinoma and Adenoma; Correlation with Clinicopathological Factors,” Journal of Clinical Pathology, Vol. 58, No. 8, 2005, pp. 833-838. doi:10.1136/jcp.2004.023416
|
[12]
|
J. K. Park, R. Hong, K. J. Kim, T. B. Lee and S. C. Lim, “Significance of p-STAT3 Expression in Human Colorectal Adenocarcinoma,” Oncology Reports, Vol. 20, No. 3, 2008, pp. 597-604. doi:10.3892/or00000047
|
[13]
|
X. T. Ma, S. Wang, Y. J. Ye, R. Y. Du, Z. R. Cui and M. Somsouk, “Constitutive Activation of Stat3 Signaling Pathway in Human Colorectal Carcinoma,” World Journal of Gastroenterology, Vol. 10, No. 11, 2004, pp. 1569-1573.
|
[14]
|
F.M. Corvinus, C. Orth, R. Moriggl, S. A. Tsareva, S. Wagner, E. B. Pfitzner, D. Baus, R. Kaufmann, L. A. Huber, K. Zatloukal, H. Beug, P. Ohlschlager, A. Schütz, K. J. Halbhuber and K. Friedrich, “Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor Growth,” Neoplasia, Vol. 7, No. 6, 2005, PP. 545-555.
doi:10.1593/neo.04571
|
[15]
|
G. Kalwitz, M. Endres, K. Neumann, K. Skriner, J. Ringe, O. Sezer, M. Sittinger, T. Haupl and C. Kaps, “Gene Expression Profile of Adult Human Bone Marrow-Derived Mesenchymal Stem Cells Stimulated by the Chemokine CXCL7,” The International Journal of Biochemistry & Cell Biology, Vol. 41, No. 3, 2009, 649-658.
doi.org/10.1016/j.biocel.2008.07.011
|